FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to an ester of phylligenin and ibuprofen with a general structural formula represented by the formula (I):
(I).
Method for the preparation of an ester (I), its antiviral use and an antiviral drug are also provided.
EFFECT: phylligenin and ibuprofen ester represented by the formula (I) may find use as an antiviral agent.
12 cl, 4 dwg, 19 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF PHILLYRIN/PHILLYGENIN COMPOSITION WHEN PREPARING A MEDICAMENT OR MEDICAL PRODUCT FOR THE RELIEF AND/OR TREATMENT OF VIRAL DISEASES AND MEDICAMENT OR MEDICAL PRODUCT FOR TREATMENT OF VIRAL DISEASES | 2014 |
|
RU2655616C1 |
| METHODS FOR CHEMICAL SYNTHESIS OF PHYLLYRINE | 2014 |
|
RU2667917C2 |
| FILLYGENIN AND GLUCURONIC ACID DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2016 |
|
RU2684100C1 |
| FORZICYASIDE SULFATE AND ITS DERIVATIVES, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2014 |
|
RU2642784C2 |
| PHILLYRIN AND ITS DERIVATIVES FOR SUPPRESSION OF THE 3CLPRO PROTEIN AND FIGHTING THE COVID-19 VIRUS | 2021 |
|
RU2804307C1 |
| KERATIN BD-11, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825992C1 |
| POLYACYLATED DERIVATIVES OF 20(R)-GINSENOSIDE RG3, PRODUCTION AND USE THEREOF | 2018 |
|
RU2695380C1 |
| ANALGETIC, ANTIPYRETIC AND ANTI-INFLAMMATORY AGENT "PENTABUFEN" | 2002 |
|
RU2222322C1 |
| MEANS FOR PREVENTION OF INTERSTITIAL PNEUMONIA | 2020 |
|
RU2747550C1 |
| POLYACYLATED DERIVATIVES OF 20(R)-GINSENOSIDE RG3, PRODUCTION AND APPLICATION THEREOF | 2014 |
|
RU2673885C1 |
